| Code | 40531 | ||||||||||
| MA number | EU/1/04/274/001 | ||||||||||
| Product Form: | plv ino 1x3,5 mg (liek.inj.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Janssen - Cilag International N.V., Belgium | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass container | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 26.04.2004 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHCP Velcade 16 01 2012.pdf
|
| Safety feature | Yes |
| Data update: | 12.10.2022 |
